Enantiomers: A new issue in pharmacotherapy of depression?;Enancjomery: Nowy problem w farmakoterapii depresji?

Psychiatria Polska

Volumn 47, Issue 3, 2013, Pages 511-518

  Grodner, Błazej ^a   Sitkiewicz, Dariusz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Depression; Fluoxetine; Psychiatry

Indexed keywords

FLUOXETINE;

ARTICLE; DEPRESSION; ENANTIOMER; HUMAN; PHARMACOGENETICS; STEREOCHEMISTRY;

ANTIDEPRESSIVE AGENTS; DEPRESSION; DEPRESSIVE DISORDER; FLUOXETINE; HUMANS; PSYCHOTROPIC DRUGS; SEROTONIN UPTAKE INHIBITORS;

EID: 84879408399     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Baumann P, Eap CB. Pharmacological, Pharmacokinetic and Clinical Aspects of chiral psychotropic drugs. Cambridge University Press; 2002.
2. Baumann P, Eap CB. Pharmacogenetics of Psychotropic Drugs. Cambridge University Press; 2002.
3. Ott RJ, Giacomini KM. Stereoselective transport of drugs across epithelia. Analytical Methods and Pharmacology; 1993; 1: 281-314.
4. White PF, Ham J, Way WL, Trevor AJ. Pharmacology of ketamine isomers in surgical patients. Anesthesiology 1980); 52: 231-239. (Pubitemid 10176862)
5. Agranat I, Caner H. Intellectual property and chirality of drugs. Drug Discov. 1999; 4: 313-321. (Pubitemid 29292399)
6. Ni YG, Miledi R. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc Natl Acad Sci. 1997; 5: 2036-2040.
7. Katzung B,Trevor A, Master S. Basic and Clinical Pharmacology. McGraw-Hill Medical USA; 2009.
8. Silva BJG, Lancas FM, Queiroz MEC. Determation of fluoxetine and norfluoxetine enantiomers in human plasma by polypyrrole-coated capillary in-tube solid-phase microextraction coupled with liquid chromatography- fluorescence detection Journal of Chromatography A. 2009; 1216: 8590-8597.
9. Stokes P, Holtz A. Fluoxetine Tenth Anniversary Update: The Progress Continues. Clinical Therapeutics. 1997; 5: 19.
10. Zienowicz M, Wisłowska A, Turzyńska D, Płaź nik A. Enancjomery i ich rola w psychopharmakologii na przykładzie escitalopramu. Farmakoterapia w psychiatrii i neurologii. 2003; 4: 71-83.
11. Ring BJ, Eckstein JA, Gillespie JS, Binkley SN, Van den Branden M, Wrighton SA. Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine. J. Pharmacol. Exp. 2001; 297: 1044-1050. (Pubitemid 32472502)
12. Stevens JC, Wrighton SA. Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450. J. Pharmacol. Exp. Ther. 1993; 266: 964-971. (Pubitemid 23318714)
13. DeVane CL, Boulton DW. Great expectations in stereochemistry: focus on antidepressants. CNS Spectrums. 2002; 7: 28-33. (Pubitemid 34663205)
14. Stevens JC, Wrighton SA. Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450. J Pharmacol Exp Ther. 1993; 266: 964-971. (Pubitemid 23318714)
15. DeVane CL, Boulton DW. Great expectations in stereochemistry: focus on antidepressants. CNS Spectr. 2002; 7: 28-33. (Pubitemid 34663205)
16. Stevens JC, Wrighton SA. Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450. J. Pharmacol. Exp. Ther. 1993; 266: 964-971. (Pubitemid 23318714)